Japan approves its first homemade oral COVID drug

Shionogi's Xocova to be used on patients with mild symptoms

20221122 Shionogi

Shionogi has a contract with Japan's health ministry to produce Xocova for 1 million patients. (Photo by Yo Inoue)

Nikkei staff writers

TOKYO -- Japan's health ministry on Tuesday granted emergency use of a COVID-19 drug developed by Shionogi, making it the country's first domestically produced oral medicine for patients with mild symptoms. The drug is expected to be available for use in early December.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.